Selected tricyclic antidepressant ingestions involving children 6 years old or less

R B McFee1, T R Caraccio, H C Mofenson

  • 1Department of Preventive Medicine, SUNY/Stony Brook, University Medical Center, Stony Brook, NY, USA. rbmcfee@pol.net

Insights

Pediatric tricyclic antidepressant (TCA) ingestions rarely cause significant toxicity in children under 6 years old. Most young children with TCA exposure, even at higher doses, remain asymptomatic, suggesting a need for revised management guidelines.

Area of Science:

  • Pediatric Toxicology
  • Emergency Medicine
  • Clinical Pharmacology

Background:

  • Tricyclic antidepressant (TCA) ingestions represent a significant cause of pediatric exposures reported to poison control centers.
  • A substantial proportion of these exposures involve young children, necessitating an understanding of their clinical manifestations and management.

Purpose of the Study:

  • To evaluate the clinical manifestations, referral patterns, healthcare facility management, and medical outcomes of pediatric patients (≤6 years) following tricyclic antidepressant ingestions.
  • To assess the relationship between ingested dose and clinical outcomes in young children with TCA exposure.

Main Methods:

  • A retrospective evaluation of pediatric patients (≤6 years) with tricyclic antidepressant ingestions managed by a regional poison control center from 1993 to 1997.
  • Data collected included TCA type, ingested dose, presence of symptoms, treatments administered (e.g., activated charcoal), healthcare facility disposition, and patient outcomes.

Main Results:

  • Of 48 pediatric patients, 92% were asymptomatic, and all exposures involved a single drug.
  • 90% ingested a dose below the typical pediatric therapeutic dose (<5 mg/kg).
  • Among those ingesting >5 mg/kg, only one child experienced mild drowsiness; no significant toxicity was observed. Activated charcoal administration did not alter outcomes.

Conclusions:

  • Unintentional tricyclic antidepressant ingestions in children aged 6 years or less are generally associated with a low risk of significant toxicity.
  • No toxicity was observed at doses below 5 mg/kg.
  • Further research is warranted to establish evidence-based clinical guidelines for the management and referral of unintentional pediatric TCA ingestions.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...